Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 4/20 | 0.38 |
| ▸ | GABRB2 | P47870 | 4/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | MGLL | Q99685 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8097087 | 0.76 | GABRA1 (0.41) | GABRA1GABRB2L3MBTL1MGLLTSHR | |
| SCHEMBL20327617 | 0.75 | GABRA1 (0.41) | GABRA1GABRB2L3MBTL1LMNAPOLB | |
| SCHEMBL22826999 | 0.75 | GABRA1 (0.41) | GABRA1GABRB2L3MBTL1LMNASMN1; SMN2 | |
| SCHEMBL5190741 | 0.75 | GABRA1 (0.41) | GABRA1GABRB2L3MBTL1LMNAALDH1A1 | |
| SCHEMBL1990817 | 0.75 | SCN4A (0.35) | ALDH1A1TSHR | |
| SCHEMBL30148621 | 0.75 | GABRA1 (0.41) | GABRA1GABRB2L3MBTL1LMNAPOLB | |
| SCHEMBL13895541 | 0.72 | GABRA1 (0.43) | GABRA1GABRB2LMNAALDH1A1 | |
| SCHEMBL9193804 | 0.68 | GABRA1 (0.52) | GABRA1GABRB2L3MBTL1MGLLMAPT | |
| SCHEMBL9190050 | 0.68 | GABRA1 (0.52) | GABRA1GABRB2L3MBTL1MGLLMAPT | |
| SCHEMBL24446439 | 0.68 | GABRA1 (0.43) | GABRA1GABRB2ALDH1A1POLBTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140018377-A1 | Aminopropenoates as Fungicides | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2014-01-16 | — | — | US | disclosed |
| US-8476197-B2 | Aminopropenoates as fungicides | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2013-07-02 | — | — | US | disclosed |
| US-20110152322-A1 | Aminopropenoates as Fungicides | BAYER CROPSCIENCE AG (DE) | 2011-06-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110152322-A1 | Aminopropenoates as Fungicides | AASDHPPT, DAO, AAAS | GABRA1 681/4885GABRB2 484/4885L3MBTL1 3219/4885 |
| US-20140018377-A1 | Aminopropenoates as Fungicides | ACMSD, AASDHPPT, AAAS | GABRA1 1550/4885GABRB2 802/4885L3MBTL1 3745/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.